Picture of Biodesix logo

BDSX Biodesix Cashflow Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapSucker Stock

Annual cashflow statement for Biodesix, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2018
December 31st
2019
December 31st
2020
December 31st
2021
December 31st
Period Length:12 M12 M12 M12 M
Source:PROSPECTUSPROSPECTUS10-K10-K
Standards:
USG
USG
USG
USG
Status:FinalFinalFinalFinal
Net Income/Starting Line-26.2-30.7-31.4-43.2
Depreciation
Non-Cash Items6.57.8511.97.17
Unusual Items
Other Non-Cash Items
Changes in Working Capital0.253-1.65-4.84.59
Change in Accounts Receivable
Change in Other Assets
Change in Payable / Accrued Expenses
Change in Other Liabilities
Cash from Operating Activities-17.7-21.7-21.4-28.2
Capital Expenditures-0.617-1.42-2.18-2.55
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items0-0.456-0.750
Acquisition of Business
Sale of Business
Cash from Investing Activities-0.617-1.87-2.93-2.55
Financing Cash Flow Items-0.283-0.119-8.25-0.5
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities192381.11.26
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash0.738-0.62656.8-29.5

Or unlock with your email

Or unlock with your email